CAPTRUST FINANCIAL ADVISORS - GLOBAL BLOOD THERAPEUTICS IN ownership

GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 235 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2020. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.

Quarter-by-quarter ownership
CAPTRUST FINANCIAL ADVISORS ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q2 2022$3,000
-66.7%
108
-58.6%
0.00%
Q1 2022$9,000
-71.9%
261
-76.4%
0.00%
Q4 2021$32,000
+28.0%
1,106
+15.0%
0.00%
Q3 2021$25,000
-16.7%
962
+11.1%
0.00%
Q2 2021$30,000
-16.7%
866
-2.0%
0.00%
Q1 2021$36,000
+227.3%
884
+233.6%
0.00%
Q4 2020$11,000
-21.4%
265
+6.0%
0.00%
Q3 2020$14,000
-22.2%
2500.0%0.00%
Q2 2020$18,000
-53.8%
250
-68.9%
0.00%
-100.0%
Q3 2019$39,000
-7.1%
805
+0.8%
0.00%
-50.0%
Q2 2019$42,0007990.00%
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q3 2020
NameSharesValueWeighting ↓
Fernwood Investment Management, LLC 355,509$17,171,0009.58%
Perceptive Advisors 4,989,066$240,971,0006.75%
GREAT POINT PARTNERS LLC 736,631$35,579,000,0005.28%
Casdin Capital, LLC 600,000$28,980,0005.10%
Avoro Capital Advisors LLC 1,765,548$85,276,0004.07%
Iguana Healthcare Management, LLC 115,000$5,555,0003.65%
Camber Capital Management LP 1,200,000$57,960,0002.85%
NEXTHERA CAPITAL LP 315,147$15,222,0002.51%
RTW INVESTMENTS, LP 456,921$22,069,0002.10%
EMORY UNIVERSITY 41,610$2,010,0001.44%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders